<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00928122</url>
  </required_header>
  <id_info>
    <org_study_id>ISCAF</org_study_id>
    <nct_id>NCT00928122</nct_id>
  </id_info>
  <brief_title>Intrastromal Correction of Ametropia by a Femtosecond Laser</brief_title>
  <acronym>ISCAF</acronym>
  <official_title>Intrastromal Correction of Ametropia by a Femtosecond Laser</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>20/10 Perfect Vision</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>20/10 Perfect Vision</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the intrastromal correction of ametropia with a femtosecond laser made
      by 20/10 PERFECT VISION. This laser generates a beam of ultrashort, infrared pulses which
      enables very precise cuts in the cornea. By these cuts lamellae of the cornea are separated
      locally, and in the consequence the curvature of the cornea is changed, and the correction of
      the diagnosed ametropia can be achieved. On the contrary to cuts which are generated with a
      sharp knife, the cuts generated when using a laser can be generated just inside the cornea
      without opening the surface of the cornea. This means the procedure is minimal-invasive.

      The study hypothesis is: Different types of ametropia can be corrected safely and on
      long-term by intrastromal cuts.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2008</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prove safety and effectiveness as well as improvement in near visual acuity performance and increase in near visual acuity.</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Validate the 3 months results</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prove stability of distance visual acuity and safety of the procedure regarding infections and inflammatory response as well as corneal endothelial cell counts.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Presbyopia</condition>
  <condition>Myopia</condition>
  <condition>Hyperopia</condition>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>1 / Presbyopia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Presbyopic patients, slightly hyperopes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 / Myopia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Myopic patients without Astigmatism</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 / Hyperopia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hyperope patients without Astigmatism</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4 / Myopia with Astigmatism</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Myopic patients incl. Astigmatism</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5 / Hyperopia with Astigmatism</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hyperope patients incl. Astigmatism</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intrastromal Correction of Presbyopia</intervention_name>
    <description>Applying defined, pre-programmed patterns (e.g. rings and/or radial cuts)into the human eye cornea. It is a minimal-invasive procedure which changes the topography of the cornea and by that the refraction ability.</description>
    <arm_group_label>1 / Presbyopia</arm_group_label>
    <other_name>- FEMTEC Laser System</other_name>
    <other_name>- Patient Interface</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intrastromal correction of Myopia</intervention_name>
    <description>Applying defined, pre-programmed patterns (e.g. rings and/or radial cuts)into the human eye cornea. It is a minimal-invasive procedure which changes the topography of the cornea and by that the refraction ability.</description>
    <arm_group_label>2 / Myopia</arm_group_label>
    <other_name>FEMTEC Laser System</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intrastromal Correction of Hyperopia</intervention_name>
    <description>Applying defined, pre-programmed patterns (e.g. rings and/or radial cuts)into the human eye cornea. It is a minimal-invasive procedure which changes the topography of the cornea and by that the refraction ability.</description>
    <arm_group_label>3 / Hyperopia</arm_group_label>
    <other_name>FEMTEC Laser System</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intrastromal Correction of Myopia incl. Astigmatism</intervention_name>
    <description>Applying defined, pre-programmed patterns (e.g. rings and/or radial cuts)into the human eye cornea. It is a minimal-invasive procedure which changes the topography of the cornea and by that the refraction ability.</description>
    <arm_group_label>4 / Myopia with Astigmatism</arm_group_label>
    <other_name>FEMTEC Laser System</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intrastromal Correction of Hyperopia incl. Astigmatism</intervention_name>
    <description>Applying defined, pre-programmed patterns (e.g. rings and/or radial cuts)into the human eye cornea. It is a minimal-invasive procedure which changes the topography of the cornea and by that the refraction ability.</description>
    <arm_group_label>5 / Hyperopia with Astigmatism</arm_group_label>
    <other_name>FEMTEC Laser System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age: &gt; 18 years

          -  stable distance refraction for at least one year (i.e. a maximum change of 0.5 D)

          -  in the case of presbyopia: minimum near add +2D to + 4D

          -  in the case of myopia or hyperopia (without astigmatism): minimal 1D and maximum 3D

          -  in the case of myopia or hyperopia (with astigmatism): spherical equivalent of minimal
             1D and maximum 3D

          -  BSCVA of the eye to be treated &gt;= 0.63

          -  patients are willing and in such conditions to come to the follow-up exams

          -  no further ocular pathologies

        Exclusion Criteria:

          -  age: &lt; 18 years

          -  refraction less than +/- 1 D or higher than +/- 3 D (not valid for presbyopia
             patients)

          -  minimal pachymetry of &lt; 500µm

          -  K-mean &lt; 37 D or &gt; 60 D

          -  Difference (K-max minus K-min) &gt; 5D

          -  Difference cycloplegic refraction to subjective refraction more than 1 D (valid only
             for hyperopia correction)

          -  patients with previous intraocular or corneal surgeries (e.g. post-LASIK or PRK
             patients). Exemption: standard cataract surgery.

          -  patients with one or more of the following ocular pathologies:

               -  keratokonus

               -  corneal scars

               -  transplanted cornea

               -  disorders of wound healing

               -  trauma

               -  glaucoma

               -  epilepsia

               -  nystagmus

               -  lack of concentration

               -  other complicated illnesses

               -  diabetes mellitus

               -  instable K-readings as a sign of instable cornea

               -  weakness of connective tissue

               -  sensitivity against the drugs used in the study

               -  continuous wearing of contact lenses before the pre-exam, and before the surgery.
                  At least 14 days before these dates patients must abstain from wearing CL.

               -  patients in pregnancy or during lactation

               -  patients who take part in another clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerd U. Auffarth, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitäts-Augenklinik Heidelberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mike P. Holzer, PD Dr. med.</last_name>
    <phone>+49 6221 56</phone>
    <phone_ext>6999</phone_ext>
    <email>mike.holzer@med.uni-heidelberg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gerd U. Auffarth, Prof. Dr.</last_name>
    <phone>+49 6221 56</phone>
    <phone_ext>36631</phone_ext>
    <email>ga@uni-hd.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinik für Refraktive und Ophthalmo-Chirurgie des EJK Niederrhein</name>
      <address>
        <city>Duisburg</city>
        <zip>47169</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Tomalla, Dr. med.</last_name>
      <phone>+49 203 508</phone>
      <phone_ext>1711</phone_ext>
      <email>Mark.Tomalla@EJK.de</email>
    </contact>
    <investigator>
      <last_name>Mark Tomalla, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>FreeVis LASIK Zentrum Mannheim GmbH</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael C. Knorz, Prof. Dr.</last_name>
      <phone>+49 621 383</phone>
      <phone_ext>3410</phone_ext>
      <email>mannheim@freevis.de</email>
    </contact>
    <investigator>
      <last_name>Michael C. Knorz, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Augenklinik am Marienplatz AG &amp; Co. KG</name>
      <address>
        <city>Muenchen</city>
        <zip>80331</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Neuhann, Dr. med.</last_name>
      <phone>+49 89 232410</phone>
      <phone_ext>0</phone_ext>
      <email>ceo@a-a-m.de</email>
    </contact>
    <investigator>
      <last_name>Tobias Neuhann, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2009</study_first_submitted>
  <study_first_submitted_qc>June 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2009</study_first_posted>
  <last_update_submitted>February 7, 2010</last_update_submitted>
  <last_update_submitted_qc>February 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>Priv.-Doz. Dr. med. Mike P. Holzer</name_title>
    <organization>Universitaets-Augenklinik Heidelberg</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
    <mesh_term>Presbyopia</mesh_term>
    <mesh_term>Hyperopia</mesh_term>
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

